The global anesthesia and respiratory devices market size was valued at USD 50.4 billion in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. This growth is driven by the increasing prevalence of chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), which is boosting the demand for respiratory devices. In addition, the rising number of surgical procedures worldwide due to an aging population and advancements in surgical techniques are fueling the need for anesthesia devices.
Technological innovations are playing a pivotal role in the expansion of the anesthesia and respiratory devices market. The development of portable and user-friendly devices has made it easier for healthcare providers to deliver effective treatment in various settings, including home care. These advancements not only enhance patient comfort and compliance but also improve the efficiency of healthcare delivery. Innovations such as wireless monitoring systems, smart inhalers, and advanced anesthesia machines with integrated safety features are revolutionizing patient care.
Moreover, the integration of artificial intelligence and machine learning in these devices is enabling more precise and personalized treatment, further driving market growth. Furthermore, the growing awareness about the importance of respiratory health is significantly contributing to market expansion.
Respiratory devices accounted for a revenue share of 67.7% in 2023 attributed to the high prevalence of chronic respiratory diseases. Products such as ventilators, nebulizers, and oxygen concentrators are in high demand due to their critical role in managing these conditions. In addition, technological advancements in respiratory devices, including the development of portable and user-friendly models, have made them more accessible and convenient for both healthcare providers and patients. The increasing awareness about respiratory health and the importance of early diagnosis and treatment are also contributing to the growth of this segment.
The anesthesia devices segment is expected to grow at a CAGR of 5.6% during the forecast period driven by the rising number of surgical procedures globally, resulting from an aging population and advancements in surgical techniques. Innovations in anesthesia technology, such as the integration of advanced monitoring systems and the development of devices with enhanced safety features, are improving the efficiency and effectiveness of anesthesia delivery. Moreover, the increasing focus on outpatient surgeries and minimally invasive procedures is boosting the demand for anesthesia devices.
North America anesthesia and respiratory devices market dominated the market in 2023 due to the widespread adoption of advanced technology and continual advancements. This has resulted in extensive and ongoing utilization of anesthesia and respiratory equipment, further contributing to its significant market penetration. Moreover, the expansion of healthcare facilities and services, particularly hospitals, has been a key factor influencing the growth of the region's anesthesia and respiratory devices market. In addition, demographic shifts such as an aging population, increased health awareness, and rising surgical procedures have played crucial roles in shaping the market dynamics in North America.
The U.S. accounted for a significant market share of the North American anesthesia and respiratory devices market in 2023 driven by factors such as the growing elderly population, increased completion rates of casualty surgeries, and the availability of reimbursement for respiratory and anesthesia devices. For example, the Centers for Disease Control & Prevention (CDC) reported that more than 16.0 million Americans were affected by COPD.
Europe emerged as a lucrative region for the anesthesia and respiratory devices market in 2023. The region’s advanced healthcare infrastructure, coupled with a high prevalence of chronic respiratory diseases, has created a strong demand for both anesthesia and respiratory devices. In addition, Europe has a significant aging population, increasing the need for surgical procedures and anesthesia devices. The presence of major market players and ongoing technological advancements further bolster this region’s growth.
The UK anesthesia and respiratory devices market is expected to grow rapidly in the coming years, driven by several factors. Notably, the increasing number of surgical procedures and the rising incidence of respiratory conditions, such as asthma and COPD, which affect 1.2 million people in the UK, are significant contributors. COPD exacerbations are the second most common cause of emergency hospital admissions, accounting for 1 in 8 UK hospital admissions, highlighting the urgent need for effective respiratory devices. Furthermore, the adoption of advanced medical technologies and the presence of a robust healthcare infrastructure are key elements supporting the market expansion.
The anesthesia and respiratory devices market in Asia Pacific is anticipated to witness significant growth, driven by a rise in respiratory issues and an aging population. Increased government funding for research and development, in line with economic development and healthcare reforms, is also expected to fuel industry growth in the region.
Japan's anesthesia and respiratory devices market held a substantial market share in 2023. The country's increasing prevalence of chronic illnesses and elderly population is projected to drive demand for medical equipment. In addition, the market is being propelled by the growing incidence of respiratory disorders and technological advancements in device technology.
Some key companies in the anesthesia and respiratory devices market include General Electric Company, Medtronic, Teleflex Incorporated, and others. Despite the market's fragmentation, these companies are actively pursuing strategic initiatives to solidify their market positions. Notable strategies include geographic expansion, the development of innovative products, forging strategic partnerships, engaging in collaborative ventures, and pursuing mergers and acquisitions.
Medtronic plc (Medtronic) is a medical technology company that offers a range of respiratory devices, including ventilators and airway management products. Medtronic’s focus on technological advancements, such as the integration of smart technologies and enhanced monitoring systems, has strengthened its position in the market.
Teleflex Incorporated is known for its advanced airway management and anesthesia products. The company’s LMA and Rüsch brands are well-regarded for their innovative designs and effectiveness in clinical settings. Teleflex’s Arrow branded pain management portfolio, which includes catheters and disposable pain pumps, is designed to enhance patient comfort and outcomes during and after surgical procedures.
The following are the leading companies in the anesthesia and respiratory devices market. These companies collectively hold the largest market share and dictate industry trends.
In September 2024, Knack Global announced the acquisition of Merrick Management, Inc., a provider of revenue cycle management solutions for anesthesia practices, marking a significant expansion of Knack’s offerings into the anesthesia market as Merrick’s experienced management team is expected to continue to play a pivotal role in leading Knack’s newly formed Anesthesia Services division.
In June 2024, GHR Healthcare acquired United Anesthesia, a CRNA and Anesthesiologist staffing firm based in North Carolina, U.S. This strategic merger is expected to allow GHR Healthcare to expand its service offerings and providing comprehensive healthcare staffing solutions to clients nationwide.
In January 2024, GlaxoSmithKline (GSK) strategically acquired Aiolos Bio, a biopharmaceutical company focused on innovative asthma treatments. Aiolos Bio's advanced pipeline of therapies for respiratory and inflammatory conditions offered GSK promising opportunities for growth and enhanced patient care.
Report Attribute |
Details |
Market size value in 2024 |
USD 54.1 billion |
Revenue forecast in 2030 |
USD 75.9 billion |
Growth Rate |
CAGR of 5.8% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, Saudi Arabia, UAE, Kuwait, South Africa |
Key companies profiled |
General Electric Company; Medtronic; Teleflex Incorporated.; Koninklijke Philips N.V.; Drägerwerk AG & Co. KGaA; Getinge; Smiths Group plc; Fisher & Paykel Healthcare Limited; Masimo; B. Braun SE; ResMed; Shenzhen Mindray Bio-Medical Electronics Co., Ltd. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global anesthesia and respiratory devices market report based on product and region.
Product Outlook (Revenue, USD Million, 2018 - 2030)
Respiratory Devices
Respiratory Equipment
Humidifiers
Heat Humidifiers
Heated Wire Breathing Circuits
Heat Exchangers
Pass Over Humidifiers
Nebulizers
Pneumatic Nebulizers
Mesh Nebulizers
Ultrasonic Nebulizers
Oxygen Concentrator
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Positive Airway Pressure Devices
Bilevel & Automatic Positive Airway Pressure Devices
Continuous Positive Airway Pressure Devices
Reusable Resuscitators
Ventilators
Adult Ventilators
Neonatal Ventilators
Respiratory Inhalers
Dry Powdered Inhalers
Metered Dose Inhalers
Respiratory Disposables
Disposable Oxygen Masks
Resuscitators
Tracheostomy Tubes
Oxygen Cannula
Respiratory Measurement Devices
Pulse Oximetry systems
Capnographs
Spirometers
Peak Flowmeters
Anesthesia Devices
Anesthesia Machines
Anesthesia Workstation
Anesthesia Delivery Machines
Portable
Standalone
Anesthesia Ventilators
Anesthesia Monitors
Anesthesia Disposables
Anesthesia Masks
Anesthesia Accessories
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
b. Some key players operating in the anesthesia and respiratory devices market include General Electric Company, Medtronic, Teleflex Incorporated, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Getinge AB., Smiths Group plc, Fisher & Paykel Healthcare Limited, Masimo, B. Braun Melsungen AG, ResMed, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Inogen, Inc., Caire Medical (a subsidiary of NGK Spark Plug), DeVilbiss Healthcare (a subsidiary of Drive Medical)., React Health (Respiratory Product Line from Invacare Corporation), O2 Concepts, Nidek Medical Products, Inc., Omron Corporation, GE Healthcare, Allied Healthcare, Vectura Group Plc., PARI Respiratory Equipment, Inc., Aerogen, DeVilbiss Healthcare LLC, Briggs Healthcare, and Beurer GmBH
b. Key factors that are driving the anesthesia and respiratory devices market growth include increasing demand for anesthesia and respiratory devices, an increase in the incidence of respiratory disorders, fast urbanization, an increase in surgical operations, an increase in pollution levels, a rise in the elderly population, and an increase in cigarette use.
b. The global anesthesia and respiratory devices market size was estimated at USD 54.1 billion in 2024 and is expected to reach USD 57.0 billion in 2025.
b. The global anesthesia and respiratory devices market is expected to grow at a compound annual growth rate of 5.9% from 2025 to 2030 to reach USD 75.9 billion by 2030.
b. North America dominated the anesthesia and respiratory devices market with a share of 25.5% in 2024. This is attributable to the increasing geriatric population, high investments by pharmaceutical companies, and rising healthcare expenditure.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."